| |
|
February
2008 |
 |
We invite you to join the GfK U.S. Healthcare Companies March 9-11 in Phoenix at the Pharmaceutical Marketing Research Group’s Annual National Conference (ANC), Crystal Ball: Today’s Information – Tomorrow’s Insights. The event promises to be an engaging exploration of the role marketing research plays in supporting the critical decisions of the future.
To kick off the conference, on Sunday, March 9 at 3:45 p.m., Richard B. Vanderveer, Ph.D., Group CEO of the GfK U.S. Healthcare Companies, will look into the crystal ball for pharma and present the following workshop:
|
|
Dr. Vanderveer’s presentation will provide an appropriate big-picture backdrop against which PMRG attendees can contextualize the case studies, methodologies and innovative approaches that will comprise the balance of the program agenda. Parallel to the conference theme of marketing research as a crystal ball for predicting the future, this presentation will offer a glimpse at the structure and inner workings of the crystal ball itself – the pharmaceutical marketing research profession – and examine the form, function and future of the environment within which the bulk of the industry’s research takes place: the agencies.
The workshop will explore the 10 dimensions that characterize pharmaceutical marketing research agencies. As Dr. Vanderveer will highlight, these are the issues that should be considered in establishing and managing, and potentially joining – or contracting with – a pharmaceutical marketing research agency that will best be able to deal with changes on the horizon in our industry, including shifts in geographic focus, issues being studied, etc.
In addition to the obvious appeal of the session to agency-side research personnel, pharmaceutical manufacturer-side research personnel will also benefit from attending the workshop as they must consider these issues so they can be sure to partner with agencies most appropriately matched to their specific set of circumstances and needs, to be ready for the future. In addition, the information will assist those client-side researchers, who in the future may seek a different career path and will want to join agencies that have up-to-date structures and core competencies.
As Dr. Vanderveer will convey in the workshop, it is important to point out that for many of these dimensions there is not necessarily a right or wrong answer. Rather, the key message is that as we look to the future, these 10 dimensions will need to be considered both individually and collectively to ensure a match between agency and client needs and concerns, and to ensure an organization’s ability to provide optimal performance in the age of Pharmaceutical Marketing 2.0.
- Geography
- Size
- General Versus Specialty
- Methodologies Employed
- Field Versus Full Service
- Secondary Data
- Sales Model
- Client Contact
- No-Compete Agreements
- Training-Oriented Versus “Black Box”
|
|
We encourage you to take a look at the full conference program and consider joining the GfK U.S. Healthcare Companies and hundreds of other industry colleagues at the PMRG 2008 Annual National Conference.
The PMRG Annual National Conference
March 9-11, 2008
Phoenix, AZ
Click here for the full conference agenda
Representing the GfK U.S. Healthcare Companies at PMRG:
, Group CEO, GfK U.S. Healthcare Companies
, President, GfK V2, Group COO, GfK U.S. Healthcare Companies
, President, GfK Market Measures
, Executive Vice President, GfK V2
, Senior Vice President, GfK Strategic Marketing
, Senior Director, GfK Strategic Marketing
, Senior Vice President, GfK Market Measures
, Vice President, GfK Market Measures
, Associate Vice President, GfK Market Measures
|
       |
   |
Prophesying the Future of Pharmaceutical MR Agencies: GfK's Workshop at the PMRG 2008 ANC, Sunday, March 9
